Physician profile
Roy R Johnson
NPI 1568487973
$910.91
in general payments reported to CMS, 2019-2025
16 companies · $14.86 in 2025
The $14.86 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $147 · 2021: $245 · 2023: $131 · 2024: $44.94 · 2025: $14.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.39 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $295.34 | 2019-2023 | |
| Amgen INC. | $169.61 | 2019 | |
| Currax Pharmaceuticals LLC | $63.87 | 2023 | Nexletol, Onzetra Xsail, Contrave |
| Novo Nordisk INC | $55.04 | 2021-2024 | Wegovy |
| Sunovion Pharmaceuticals INC. | $49.16 | 2019 | |
| Exact Sciences Corporation | $44.82 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $40.22 | 2021 | |
| Lilly USA, LLC | $32.78 | 2019-2021 | |
| Glaxosmithkline, LLC. | $31.32 | 2021 | |
| Allergan, INC. | $26.17 | 2020 | |
| Radius Health, INC. | $22.42 | 2023 | |
| Novartis Pharmaceuticals Corporation | $20.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2024 | |
| Cranial Technologies, INC | $14.24 | 2024 | Doc Band |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.